
Keywords: AAV; adeno-associated viruses; AMS; activated macrophage suspension; Ang; angiopoietin; APC; activated protein C; antimiRs; miRNA antisense oligonucleotides; bFGF; basic FGF; BM; bone marrow; cDNA; complementary DNA; CLI; critical limb ischemia; CRISPR-Ca